Drug Discovery and Development

HORIBA supports the discovery and development of drug products by pharmaceutical industries, which require an extraordinary amount of time and effort to get to the final delivery to customers. During its entire lifecycle, the quality of the pharmaceuticals is one of the most critical steps, as it continually faces challenges from government and regulatory agencies to ensure quality and efficacy. From drug discovery to post-marketed products, HORIBA provides fast and innovative characterization solutions for all the scientific fields involved.

Browse Application

Validation of the activity of G-protein-coupled receptors (GPCRs) using SPRi
Raman Microscopy in Pharmaceutical Salt Analysis
Raman Microscopy in Pharmaceutical Salt Analysis
Pharmaceutical and crystallographic samples typically require detailed characterization and analysis to optimize a samples stability, physical properties and indeed general efficacy where an active drug substance is involved.
The Detection of a Low Molecular Weight Enzyme Inhibitor using the OpenPlex™ system
The Detection of an Ultralow Molecular Weight Enzyme Inhibitor using the XelPleX system
Raman Analysis and characterization of pharmaceuticals
Polymorphy in pharmaceuticals by Raman Spectroscopy
Investigating the atherosclerosis process by monitoring lipid deposits including cholesterol and free fatty acids
Characterization and mapping of active pharmaceutical ingredients and excipients in a tablet using Raman and IR spectroscopy
Kinetic Fluorescence Determination of Vitamin B1
This technical note describes kinetic fluorescence as an analytical technique to quantify non-fluorescent species. The technique is applied to the determination of thiamine (vitamin B1) in solution.
Char of Compounds in a pharmaceutical drug product